Particle.news

AI Models Designed Viable Bacteriophages That Worked in the Lab

The Science paper shows rapid therapeutic promise for phage therapy while the authors’ open release of models exposes a governance gap that experts say requires new screening and access rules.

Overview

  • Researchers at Stanford and the Arc Institute used genome‑language models called Evo 1 and Evo 2 to generate complete phage genomes and tested about 285 synthetic candidates in the lab.
  • Sixteen of the AI‑designed phages replicated in Escherichia coli, one named Evo‑Φ69 outperformed the natural ΦX174 in competition tests, and a mixture of synthetic phages overcame resistance in three E. coli strains.
  • The study’s authors published model code and weights publicly and warned that retraining the models on other data could enable misuse, prompting immediate calls from experts for technical safeguards.
  • Commentators and biosecurity specialists are pressing for concrete measures such as mandatory synthetic‑DNA screening, risk‑tiered access to powerful design models, genetic watermarking, and stronger verification under international rules.
  • U.S. authorities issued a July 2026 guideline that extends review to in‑silico work with potential to create dangerous agents but key regulatory details remain unresolved as policymakers and scientists weigh benefits for antibiotic‑resistant infections against dual‑use risks.